Home›Companies›Biotech & Pharma›BiomeSense

BiomeSense, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 3, 2025·Suggest an edit

About BiomeSense

BiomeSense is a private company based in Chicago, Illinois. It has reported $15,663,189 raised in three offerings on Form D since October 2019. Its chief executive is Kevin Honaker.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 18, 2025Nov 3, 2025$7,059,599of $7.2M target27$261KOptionsRule 506(b)Form D ↗
Feb 14, 2023Dec 19, 2023$6,178,594of $6.5M target33$187KEquityRule 506(b)Form D ↗
Sep 17, 2019Oct 2, 2019$2,424,996of $2.4M target5$484KEquityRule 506(b)Form D ↗
Total, three offerings$15,663,189

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on BiomeSense's Form D filed Nov 3, 2025.

DN
AH
KH
Kevin Honaker
CEO and director
VG

Earlier filings also listed Parikshit Sharma (director, last listed Dec 2023) and Orhan Ertughrul (director, last listed Oct 2019).

Sources

  1. SECBiomeSense, Inc. filing history